Recursion

Latest Posts

In a latest transaction, Blake Borgeson, a director at Recursion Prescribed drugs, Inc. (NASDAQ:RXRX),...

Market

Recursion Prescribed drugs director sells $81,532 in firm inventory By Investing.com

Salt Lake Metropolis, June 26, 2024 (GLOBE NEWSWIRE) -- Recursion Prescribed drugs, Inc. (Recursion)...

Market

Recursion Declares Pricing of $200 Million Public Providing of Class A Frequent Inventory By Investing.com